异动解读 | AtriCure股价盘中暴跌16.87%，多家券商下调目标价

异动解读2025-04-30

4月30日周三，医疗设备制造商AtriCure（股票代码：ATRC）股价在盘中出现大幅下跌，截至发稿时跌幅高达16.87%。这一显著跌幅引发了投资者的广泛关注。

造成AtriCure股价暴跌的主要原因是多家知名券商同时下调了该公司的目标价。其中，Needham将AtriCure的目标价从51美元下调至44美元，降幅达13.7%。同时，瑞银也将其目标价从60美元下调至58美元。这些目标价的下调反映了分析师对AtriCure未来业绩预期的下降，从而引发了投资者的抛售行为。

AtriCure是一家专注于心房颤动（Afib）、左心耳（LAA）管理和术后疼痛管理的外科治疗和疗法创新者。目标价的下调可能意味着分析师对公司在这些领域的市场前景或财务表现持谨慎态度。投资者应密切关注公司未来的财报和业务发展情况，以评估这次股价大跌是否会对AtriCure的长期发展产生实质性影响。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1194512931?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-30 22:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1194512931","market":"nz","top_or_hot":-1,"title":"异动解读 | AtriCure股价盘中暴跌16.87%，多家券商下调目标价","media":"异动解读","content":"<p>4月30日周三，医疗设备制造商AtriCure（股票代码：ATRC）股价在盘中出现大幅下跌，截至发稿时跌幅高达16.87%。这一显著跌幅引发了投资者的广泛关注。</p>\n\n<p>造成AtriCure股价暴跌的主要原因是多家知名券商同时下调了该公司的目标价。其中，Needham将AtriCure的目标价从51美元下调至44美元，降幅达13.7%。同时，瑞银也将其目标价从60美元下调至58美元。这些目标价的下调反映了分析师对AtriCure未来业绩预期的下降，从而引发了投资者的抛售行为。</p>\n\n<p>AtriCure是一家专注于心房颤动（Afib）、左心耳（LAA）管理和术后疼痛管理的外科治疗和疗法创新者。目标价的下调可能意味着分析师对公司在这些领域的市场前景或财务表现持谨慎态度。投资者应密切关注公司未来的财报和业务发展情况，以评估这次股价大跌是否会对AtriCure的长期发展产生实质性影响。</p>","source":"ai_movement_cn","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读 | AtriCure股价盘中暴跌16.87%，多家券商下调目标价</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读 | AtriCure股价盘中暴跌16.87%，多家券商下调目标价\n</h2>\n\n<h4 class=\"meta\">\n\n2025-04-30 22:42 北京时间&nbsp;&nbsp;&nbsp;<strong>异动解读</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>4月30日周三，医疗设备制造商AtriCure（股票代码：ATRC）股价在盘中出现大幅下跌，截至发稿时跌幅高达16.87%。这一显著跌幅引发了投资者的广泛关注。\n造成AtriCure股价暴跌的主要原因是多家知名券商同时下调了该公司的目标价。其中，Needham将AtriCure的目标价从51美元下调至44美元，降幅达13.7%。同时，瑞银也将其目标价从60美元下调至58美元。这些目标价的下调反映了...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ATRC","symbol_name":"AtriCure公司","start_time":0,"source_url":"","article_id":"1194512931","we_media_id":"1092702339","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1194512931","pubTimestamp":1746024156,"columns":[],"sourceInfo":{"source_id":"ai_movement_cn","name":"异动解读"},"weMediaInfo":{"media_name":"异动解读","introduction":"个股异动一手消息解读","home_visible":1,"id":"1092702339","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"4月30日周三，医疗设备制造商AtriCure股价在盘中出现大幅下跌，截至发稿时跌幅高达16.87%。这一显著跌幅引发了投资者的广泛关注。造成AtriCure股价暴跌的主要原因是多家知名券商同时下调了该公司的目标价。其中，Needham将AtriCure的目标价从51美元下调至44美元，降幅达13.7%。AtriCure是一家专注于心房颤动、左心耳管理和术后疼痛管理的外科治疗和疗法创新者。投资者应密切关注公司未来的财报和业务发展情况，以评估这次股价大跌是否会对AtriCure的长期发展产生实质性影响。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"ATRC":"AtriCure公司"},"translate_title":"Interpretation of the change AtriCure stock price plummeted 16.87% intraday, and many brokerages lowered their target prices","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ATRC":1},"content_text":"4月30日周三，医疗设备制造商AtriCure（股票代码：ATRC）股价在盘中出现大幅下跌，截至发稿时跌幅高达16.87%。这一显著跌幅引发了投资者的广泛关注。\n造成AtriCure股价暴跌的主要原因是多家知名券商同时下调了该公司的目标价。其中，Needham将AtriCure的目标价从51美元下调至44美元，降幅达13.7%。同时，瑞银也将其目标价从60美元下调至58美元。这些目标价的下调反映了分析师对AtriCure未来业绩预期的下降，从而引发了投资者的抛售行为。\nAtriCure是一家专注于心房颤动（Afib）、左心耳（LAA）管理和术后疼痛管理的外科治疗和疗法创新者。目标价的下调可能意味着分析师对公司在这些领域的市场前景或财务表现持谨慎态度。投资者应密切关注公司未来的财报和业务发展情况，以评估这次股价大跌是否会对AtriCure的长期发展产生实质性影响。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1194512931","isCrawlerRequest":true}